• Users Online: 51351
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response
Swathi Kaliki,Kavya Madhuri Bejjanki,Akruti Desai,Ashik Mohamed
Seminars in Ophthalmology.2019;34(7-8)465
[DOI]
2Recombinant interferon Alpha-2b as primary treatment for ocular surface squamous neoplasia
Reza Ghaffari,Sahar Barijani,Arash Alivand,Golshan Latifi,Hamed Ghassemi,Mehran Zarei-Ghanavati,AliR Djalilian
Journal of Current Ophthalmology.2021;33(3)260
[DOI]
3Interferon Alpha 2a and 2b in Ophthalmology: A Review
Natalia Lewczuk,Alexander Zdebik,Joanna Boguslawska
Journal of Interferon & Cytokine Research.2019;39(5)259
[DOI]
4Interferon Alfa-2b for Pigmented Ocular Surface Squamous Neoplasia: A Report of 8 Lesions
Swathi Kaliki,Abhimanyu Sharma,Vijitha S. Vempuluru
Cornea.2021;40(2)142
[DOI]
5Ocular surface complications of local anticancer drugs for treatment of ocular tumors
Jayoon Moon,Se Hyun Choi,Min Joung Lee,Dong Hyun Jo,Un Chul Park,Sun-Ok Yoon,Se Joon Woo,Joo Youn Oh
The Ocular Surface.2021;19(2)16
[DOI]
6Ocular surface squamous neoplasia: management and outcomes
Roland H?llhumer,Susan Williams,Pamela Michelow
Eye.2021;35(6)1562
[DOI]
7dsRNA Induced IFNß-MMP13 Axis Drives Corneal Wound Healing
Xihong Lan,Wang Zhang,Jin Zhu,Huaxing Huang,Kunlun Mo,Huizhen Guo,Liqiong Zhu,Jiafeng Liu,Mingsen Li,Li Wang,Chunqiao Liu,Jianping Ji,Hong Ouyang
Investigative Opthalmology & Visual Science.2022;63(2)14
[DOI]
8dsRNA Induced IFNß-MMP13 Axis Drives Corneal Wound Healing
Lingam Gopal,Gangadhara Sundar,Su Xinyi
Investigative Opthalmology & Visual Science.2021;63(2)1
[DOI]
9Comment on: “Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium After the Bare Sclera Technique: A Single-Center, Sequential, and Controlled Study”
Barkha Gupta,Pranita Sahay,Devesh Kumawat
Cornea.2020;39(4)e13
[DOI]
10Treatment outcome with interferon alpha 2b in ocular surface squamous neoplasia: Recommendation as primary treatment by peripheral ophthalmologists
Rachna Meel,Rebika Dhiman,Murugesan Vanathi,Seema Sen,Noopur Gupta,Radhika Tandon
Oman Journal of Ophthalmology.2021;14(1)27
[DOI]
11Ocular surface squamous neoplasia in Northern Thailand: a 16-year review
Napaporn Tananuvat,Muanploy Niparugs,Damrong Wiwatwongwana,Nirush Lertprasertsuk,Pongsak Mahanupap
BMC Ophthalmology.2022;22(1)27
[DOI]
12Long term study of topical interferon a-2b eye drops as primary treatment of ocular surface squamous neoplasia
Wathanee Sripawadkul,Daniela Reyes-Capo,Mike Zein,Adam Wylegala,Ghada Albayyat,Anat Galor,Carol L. Karp
The Ocular Surface.2023;28(1)108
[DOI]
13Adenosquamous Carcinoma Arising in Bulbar Conjunctiva
Satoru Kase,Susumu Ishida
Ophthalmic Plastic & Reconstructive Surgery.2019;35(5)e109
[DOI]
14WITHDRAWN: The outcome of subconjunctival pegylated interferon injections on Xeroderma Pigmentosum experience in a tertiary care center
Qais S. Dirar,Hebah M. Musalem,Selwa Alhazzaa,Abdulaziz A. Al Zoba,Amal A. Almalki
American Journal of Ophthalmology Case Reports.2020;35(5)100645
[DOI]
15Giant Ocular Surface Squamous Neoplasia Wrapping the Whole Cornea
Rebika Dhiman,Rachna Meel
Eye & Contact Lens: Science & Clinical Practice.2018;44(1)S374
[DOI]
16Ocular Surface Squamous Neoplasia: Changes in the Standard of Care 2003 to 2022
Jason A. Greenfield,Adam K. Cohen,Anat Galor,James Chodosh,Donald Stone,Carol L. Karp
Cornea.2024;44(1)S374
[DOI]
17An update in the management of ocular surface squamous neoplasia
Nefeli Eleni Kounatidou,Sotiria Palioura
Expert Review of Ophthalmology.2021;16(4)255
[DOI]
18High-Resolution Anterior Segment Optical Coherence Tomography in Intraepithelial Versus Invasive Ocular Surface Squamous Neoplasia
Swati Singh,Ruchi Mittal,Arnav Ghosh,Devjyoti Tripathy,Suryasnata Rath
Cornea.2018;37(10)1292
[DOI]
19Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up study
Adam Wylegala,Wathanee Sripawadkul,Mike Zein,Osmel P. Alvarez,Ghada Al Bayyat,Anat Galor,Carol L. Karp
The Ocular Surface.2023;27(10)67
[DOI]
20Recombinant interferon Alpha-2b as primary treatment for ocular surface squamous neoplasia
Reza Ghaffari,Sahar Barijani,Arash Alivand,Golshan Latifi,Hamed Ghassemi,Mehran Zarei-Ghanavati,AliR Djalilian
Journal of Current Ophthalmology.2021;33(3)260
[DOI]
21Influence of Lacidophilin Vaginal Capsules plus rh-IFN-a2b on Efficacy, Vaginal Microecology, and Safety of Patients with HPV Infection
Yan Sun,Jianqun Xu,Hongya Zhou,Lina You,Yan Zhu,Shoib Baba
Evidence-Based Complementary and Alternative Medicine.2022;2022(3)1
[DOI]
22Clinical Management of Ocular Surface Squamous Neoplasia: A Review of the Current Evidence
Maria Vittoria Cicinelli,Alessandro Marchese,Francesco Bandello,Giulio Modorati
Ophthalmology and Therapy.2018;7(2)247
[DOI]
23Topical interferon alpha-2b for a giant ocular surface squamous neoplasia: 7 years of follow-up after complete remission
Virgilio Galvis,Nathalia J Moreno,Alejandro Tello,Néstor I Carreño
BMJ Case Reports.2021;14(2)e240994
[DOI]
24Topical interferon alpha-2b for a giant ocular surface squamous neoplasia: 7 years of follow-up after complete remission
Eman Ali Saeed Alghamdi,Abdulmalik Yahya Al Qahtani,Mazen M. Sinjab,Khalid Mohammed Alyahya
BMJ Case Reports.2020;14(2)25
[DOI]
25Widespread Ocular Surface Squamous Neoplasia Treated with Topical Interferon Alpha-2b
Hershel Patel,Lauren J. Jeang,Ankit Shah,Edgar M. Espana,Curtis E. Margo
Ocular Oncology and Pathology.2018;4(5)298
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal